nivolumab
bms
['remain trial', 'leukemia', 'nivo', 'leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'nivolumab']
#ash22 #leusm liu: remain trial: nivolumab maintenance for aml in remission after chemotherapy. pdl1 expression upregs on leukemia blasts after chemo exposure. randomized non-hct eligible aml pts in cr1 between nivo q2wks vs observation. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)